Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 2 minute read General business news Sagar Cements reports 19% revenue decline in Q2 FY25 amidst tough market conditions Sagar Cements Ltd. has reported a 19% decline in revenue for the second quarter of FY25, amounting to… byPallavi MadhirajuOctober 24, 2024